Xueying Zhang Selected Research

Doxorubicin (Adriamycin)

11/2022

Matrix Metalloproteinase-2-Responsive Surface-Changeable Liposomes Decorated by Multifunctional Peptides to Overcome the Drug Resistance of Triple-Negative Breast Cancer through Enhanced Targeting and Penetrability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xueying Zhang Research Topics

Disease

21	Neoplasms (Cancer) 02/2024 - 07/2013
13	Inflammation (Inflammations) 07/2023 - 05/2012
10	Infections 12/2023 - 01/2016
6	Body Weight (Weight, Body) 02/2024 - 01/2018
6	Esophageal Squamous Cell Carcinoma 02/2024 - 09/2021
6	Cognitive Dysfunction 02/2024 - 02/2016
6	Starvation 01/2024 - 01/2020
6	Carcinogenesis 06/2021 - 01/2011
5	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2020
5	Tendinopathy (Tendonitis) 11/2022 - 01/2021
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2014
4	Insulin Resistance 03/2022 - 02/2016
4	Colitis 01/2022 - 04/2020
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2020
3	Fibrosis (Cirrhosis) 02/2024 - 12/2021
3	Dysbiosis 02/2024 - 01/2021
3	Wounds and Injuries (Trauma) 01/2024 - 12/2021
3	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2019
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2023 - 04/2016
3	Obesity 05/2023 - 01/2018
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 05/2019
3	Osteoporosis 01/2023 - 01/2022
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 01/2013
3	Liver Diseases (Liver Disease) 01/2022 - 12/2021
3	Constipation 01/2021 - 01/2017
3	Myocardial Infarction 01/2015 - 09/2013
2	Diabetic Angiopathies (Diabetic Angiopathy) 12/2023 - 02/2022
2	Neuroinflammatory Diseases 07/2023 - 01/2022
2	Postoperative Cognitive Complications 07/2023 - 01/2021
2	Rotator Cuff Injuries 01/2023 - 01/2022
2	Non-alcoholic Fatty Liver Disease 03/2022 - 01/2022
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2022
2	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2022 - 10/2011
2	Premature Birth (Birth, Premature) 12/2021 - 01/2020
2	Weight Loss (Weight Reduction) 05/2021 - 05/2018

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2013
8	Long Noncoding RNAIBA 10/2023 - 01/2016
8	Proteins (Proteins, Gene)FDA Link 07/2023 - 09/2013
6	Messenger RNA (mRNA)IBA 07/2023 - 01/2019
6	CytokinesIBA 07/2023 - 05/2015
5	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2016
5	LipidsIBA 01/2023 - 12/2021
4	Peptides (Polypeptides)IBA 02/2024 - 09/2013
4	Phosphates (Orthophosphate)IBA 01/2024 - 10/2021
4	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 01/2020
4	Dextran SulfateIBA 01/2022 - 01/2020
4	oxidized low density lipoproteinIBA 01/2022 - 01/2015
4	Immunoglobulin G (IgG)IBA 12/2021 - 01/2015
4	CateninsIBA 06/2021 - 01/2020
3	Anthocyanins (Anthocyanin)IBA 01/2024 - 01/2021
3	Cell-Free Nucleic AcidsIBA 12/2023 - 01/2023
3	Interleukin-6 (Interleukin 6)IBA 07/2023 - 05/2014
3	CarbohydratesIBA 01/2022 - 01/2018
3	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2016
3	Dietary Fats (Dietary Fat)IBA 01/2022 - 01/2018
3	AntibodiesIBA 12/2018 - 01/2015
3	Protein Kinases (Protein Kinase)IBA 09/2015 - 01/2011
2	EnzymesIBA 02/2024 - 01/2020
2	Cholinergic Agents (Cholinergics)IBA 02/2024 - 12/2021
2	Protein Hydrolysates FDA Link 02/2024 - 12/2021
2	Indicators and Reagents (Reagents)IBA 01/2024 - 05/2019
2	Transcription Factors (Transcription Factor)IBA 01/2024 - 01/2021
2	Nitrogen DioxideIBA 12/2023 - 05/2020
2	Particulate MatterIBA 12/2023 - 12/2021
2	Interferon Type IIBA 12/2023 - 01/2016
2	Circular RNAIBA 12/2023 - 01/2022
2	AlkaloidsIBA 01/2023 - 01/2022
2	Denosumab FDA Link 01/2023 - 01/2022
2	abaloparatideIBA 01/2023 - 01/2022
2	phthalic acid (phthalate)IBA 01/2023 - 01/2022
2	Therapeutic UsesIBA 01/2023 - 06/2017
2	Hormones (Hormone)IBA 01/2023 - 01/2021
2	Anabolic AgentsIBA 01/2023 - 01/2022
2	C-Reactive ProteinIBA 12/2022 - 01/2017
2	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2022 - 01/2020
2	AntioxidantsIBA 10/2022 - 01/2021
2	Neuroprotective AgentsIBA 10/2022 - 12/2021
2	Streptozocin (Streptozotocin)FDA Link 02/2022 - 01/2013
2	Blood Glucose (Blood Sugar)IBA 02/2022 - 01/2022
2	Oxidoreductases (Dehydrogenase)IBA 02/2022 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
2	artenimol (dihydroartemisinin)IBA 01/2022 - 01/2020
2	Dextrans (Dextran)FDA Link 01/2022 - 04/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 06/2017
2	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2020
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 04/2020
2	Immunoglobulin A (IgA)IBA 12/2021 - 01/2021

Therapy/Procedure

11	Therapeutics 02/2024 - 07/2013
4	Fecal Microbiota Transplantation 01/2022 - 01/2017
3	Length of Stay 01/2022 - 01/2021
2	Immunotherapy 01/2024 - 04/2014
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2020
2	Radiotherapy 01/2024 - 04/2020
2	Transplantation 12/2022 - 01/2021
2	Surgical Instruments (Clip) 02/2022 - 01/2021
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 10/2021
2	Ovariectomy (Oophorectomy) 01/2022 - 01/2021
2	Liver Transplantation 01/2021 - 01/2021